Polymers in Medicine

Polim. Med.
Scopus CiteScore: 3.5
MNiSW - 70
ISSN 0370-0747 (print)
ISSN 2451-2699 (online) 
Periodicity – biannual

Instructions for Authors

General Rules

The Editorial Board welcomes submissions that fall within the journal’s scope. Please note the following general requirements:

Language

  • The Editorial Board accepts for publication only manuscripts written in US English.

  • Authors who are not entirely familiar with academic English usage are strongly advised to seek assistance from a fluent English speaker or professional language editor prior to submission.

  • Please note that correct language style is the responsibility of the authors. The journal does not offer translation services.

Online publication (Ahead of Print)

Please note that if your paper is accepted for publication, it will first be published online as an Ahead of Print article as soon as possible. This version includes:

  • an active DOI

  • registration/indexing in PubMed

  • no page numbers at this stage

Later, the same paper will be assigned to a regular journal issue and will receive final page numbers. The DOI does not change. Since issue contents are planned in advance, the time between online publication and issue assignment may vary.

Editorial policy

  • The journal offers neither fast-track nor priority publication in any form.

  • The Editorial Office does not perform pre-assessment of manuscripts sent by e-mail regarding their scope suitability or publication likelihood. All manuscripts should be submitted through the official submission procedure.

Compliance with guidelines

Manuscripts not conforming to the rules listed in these Instructions for Authors may be returned to the authors for technical correction and will not be sent for peer review until they are adjusted appropriately.
Conformity to the Instructions for Authors is the authors’ responsibility.

Submission Checklist (before you submit)

To ensure a smooth and efficient editorial process, please confirm that your submission meets the requirements below:

Language and style

  • The manuscript is written in US English (consistent spelling and terminology).

  • The manuscript has been thoroughly language-checked (recommended if applicable).

  • The writing is clear, academic, and grammatically correct.

Manuscript files

  • The manuscript is submitted in an editable format (DOC/DOCX preferred).

  • Figures are provided in high quality as separate files (TIFF/JPG/PNG; recommended min. 300 dpi).

  • Tables are editable (not submitted as images).

Manuscript structure

  • Title page includes:

    • manuscript title

    • full names of all authors

    • affiliations

    • corresponding author details (email and full address)

  • Abstract is complete and reflects the main findings.

  • 4–8 keywords are provided.

  • The manuscript follows a standard scientific structure (as applicable).

Declarations

  • Conflict of Interest statement included (or “The authors declare no conflicts of interest.”).

  • Funding statement included (or “This research received no external funding.”).

  • All authors have approved the final submitted version and authorship order.

Ethics (if applicable)

  • Ethics committee/IRB approval statement is included (human/animal studies).

  • Informed consent is confirmed where required.

  • Patient confidentiality is protected.

References and technical consistency

  • References are complete and formatted consistently.

  • All cited references appear in the reference list (and vice versa).

  • DOIs are included where available.

  • Figures and tables are cited in the text in correct order.

  • Units follow SI standards where applicable.

  • Polymer/material nomenclature is clear (composition, grade, key characteristics where relevant).

Submission of manuscripts (double-blind peer review)

Online submission

All manuscripts must be submitted through the journal’s electronic editorial management system:
https://www.editorialsystem.com/pim/

Manuscripts submitted by post or e-mail will not be considered.

Double-blind peer review and anonymization

Polymers in Medicine uses a double-blind peer review process. Therefore, the manuscript must be prepared in a way that does not reveal the identity of the authors.

The main manuscript file must be fully anonymized and must not include:

  • author names and affiliations,

  • acknowledgements,

  • funding information,

  • conflict of interest statements,

  • any other information that may identify the authors (including file metadata, headers/footers, or self-identifying statements in the text).

All author names, affiliations and contact details must be entered in the Editorial System during submission.

Title page

Do not include a title page (either as the first page of the manuscript or as a separate file). The Editorial System will automatically generate the title page from the metadata provided during submission.

Please do not include an “Authors’ contributions” section in the manuscript file.

Running title

Authors are required to provide a running title (maximum 45 characters including spaces) during submission.

Funding and conflicts of interest

Authors must disclose all financial and material support during submission in the Editorial System:

  • Funding sources must be entered in the dedicated “Funding” section.

  • Conflicts of interest must be declared in the dedicated “Conflict of Interest” section.

To preserve the double-blind review process, information on funding, conflicts of interest and acknowledgements must be provided only in the Editorial System and must be removed from the main manuscript file.

How to create an account in the Editorial System

The Editorial Office of Polymers in Medicine understands that creating an account in the Editorial System (used for manuscript submission and peer review) may occasionally be challenging for authors and reviewers.

To assist you, we provide a step-by-step PDF guideline (including screenshots and comments) available below:

Guideline – How to create an account in the Editorial System (PDF)

If you experience any difficulties, please contact the Managing Editor:
Paulina Piątkowska
paulina.piatkowska@umw.edu.pl

Upon request, the Managing Editor can assist you in setting up an account so that you can proceed directly with login and submission.

Preprints

Polymers in Medicine supports open science and endorses the posting of manuscripts as preprints. Authors are encouraged to deposit preprint versions of their manuscripts on non-profit preprint servers, including (but not limited to): bioRxiv, medRxiv, Research Square, Authorea, as well as on authors’ personal or institutional websites.

Posting a manuscript as a preprint does not constitute prior publication and does not prevent the manuscript from being considered for publication in Polymers in Medicine. Preprinted manuscripts may enter peer review following the journal’s standard submission procedure.

Timing and version requirements

Preprints may be posted before submission or during peer review, provided that:

  • the deposited version is created before journal submission, and

  • the preprint text is not modified as a result of peer-review comments.

Preprints should not be posted after the manuscript has been accepted for publication in the journal.

If a preprint is posted after submission to Polymers in Medicine, authors are kindly asked to inform the Editorial Office by e-mail.

Disclosure of preprints during submission

A preprint is defined as an author’s version of a research manuscript prior to formal peer review at a journal, deposited on a public server.

If the submitted manuscript is already accessible online as a registered preprint (e.g., assigned a DOI), authors must:

  • provide the preprint DOI and URL in the Editorial System during submission, and

  • include this information in the cover letter.

Updating the preprint record after publication

Once the manuscript is published in Polymers in Medicine, it is the authors’ responsibility to update the preprint record to include:

  • the final publication reference,

  • the final article DOI, and

  • a direct link to the published version of record on the journal website.

The Editors may periodically screen preprints corresponding to articles published in the journal to ensure that such updates have been made.

Further reading

A paper summarizing up-to-date knowledge on preprints and the journal’s preprint policy has been published in Advances in Clinical and Experimental Medicine:

Supporting open science: Advances in Clinical and Experimental Medicine and preprints

Financial disclosure / Funding 

Authors must provide a complete and transparent Funding (Financial Disclosure) Statement describing all sources of financial and material support for the work reported in the manuscript.

Please prepare this information prior to submission. Changes to the Funding statement after initial submission may only be made with journal approval.

If the manuscript is accepted and published, the Funding statement will appear in the article under the Funding sources section.

What must be disclosed

All funding and support for the work must be reported without time limit, including support that could reasonably be perceived as influencing the research, interpretation, or conclusions. This includes (but is not limited to):

  • research grants,

  • institutional or departmental funding,

  • commercial sponsorship,

  • provision of materials, equipment, or reagents,

  • payments or salaries related to the submitted work.

What the Funding statement should include

The Funding statement must contain:

  • full names of funding organizations / companies,

  • grant numbers (where applicable),

  • initials of the authors who received each grant/award,

  • where applicable, the initials of authors who received salary or other financial support from commercial entities.

Role of the funder / sponsor

Authors must also state whether any sponsor or funder (other than the named authors) had any role in:

  • study design,

  • data collection and analysis,

  • decision to publish,

  • preparation of the manuscript.

If the funders had no role, please include the following sentence:

“The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.”

Where to provide funding information (submission system)

To preserve the peer-review process, funding information must be provided only via the Editorial System, in the dedicated Funding section during submission.

Please do not include funding information in:

  • Acknowledgements, or

  • the main manuscript file.

Conflict of interest

All authors are required to submit a complete Conflict of Interest (COI) disclosure prior to submission. The purpose of this disclosure is to ensure transparency regarding any relationships or activities that could be perceived as influencing the submitted work.

What should be disclosed

COI disclosures should include any financial, professional, or personal relationships that may represent a potential conflict of interest, including (but not limited to):

  • consulting fees or participation in paid advisory boards (during the past 3 years or the known future),

  • equity ownership or stock options (publicly or privately traded companies; excluding mutual funds),

  • lecture fees or honoraria for talks given at the invitation of a commercial sponsor (past 3 years or known future),

  • employment by a commercial entity related to or sponsoring the study,

  • industry grant support,

  • patents (planned, pending, or issued) and/or royalties,

  • expert testimony / expert witness activities,

  • any other activities performed for, or involving, a commercial sponsor.

If no conflicts exist, authors should declare this explicitly.

Where to report conflicts of interest

All conflict of interest information must be provided during submission in the Editorial System, in the dedicated Conflict of Interest section.

To maintain an unbiased peer-review process, COI statements should not be included in:

  • the main manuscript file, or

  • the Acknowledgements section.

Further information

More information on conflicts of interest is available here.

Declarations 

All manuscripts must include a separate section entitled “Declarations”. Under this heading, authors should provide the following statements (as applicable):

Data availability

Authors must include a Data Availability Statement. The following wording may be used where appropriate:

“The datasets generated and/or analysed during the current study are available from the corresponding author on reasonable request.”

(If relevant, authors may also provide links to public repositories and accession numbers.)

Consent for publication

Where the manuscript includes personal data, images, or other information that could identify an individual, authors must confirm whether consent for publication was obtained.

Please note: consent for publication is different from informed consent to participate in a study. In this context, “consent” refers specifically to permission to publish personal information about an individual.

Use of AI and AI-assisted technology

Authors must disclose the use of AI tools or AI-assisted technologies in the preparation of the manuscript (e.g., language editing, text generation, image generation, data analysis), in accordance with the journal’s AI policy.

Please refer to the Data sharing section below and the journal’s AI policy. for details.

Not applicable statements

If any of the above sections are not relevant to your manuscript, please include the relevant heading and state:

“Not applicable.”

Copyright declaration

By submitting a manuscript to Polymers in Medicine, the Author(s) declare and warrant that:

a) they are the copyright holder(s) of the submitted work/publication;
b) they have the full legal right and authority to grant the relevant rights and to enter into a license/publishing agreement with Wroclaw Medical University;
c) the work/publication is original and has been created by the Author(s);
d) the submitted work/publication does not infringe upon the copyright, intellectual property rights, or any other rights of third parties.

Third-party claims and liability

In the event that any third party submits a claim against Wroclaw Medical University arising from a breach of the above declarations, the Author(s) agree to indemnify and hold Wroclaw Medical University harmless from any resulting losses, damages, costs and expenses.

This includes, in particular:

  • damages and costs awarded by a competent court, or arising from a settlement agreement, and

  • the costs of legal representation and related services.

Authorship 

Authorship criteria

Authorship should be based on all of the following criteria. Each author must have:

  1. made substantial contributions to the conception or design of the work, or to the acquisition, analysis, or interpretation of data;

  2. drafted the manuscript or revised it critically for important intellectual content;

  3. given final approval of the version to be published.

All individuals designated as authors must meet all criteria, and all who meet the criteria should be identified as authors.

Group authorship (multicenter studies)

For work conducted by a large, multicenter group, the group should identify the individuals who accept direct responsibility for the manuscript. The submitting author should:

  • provide the group name (if applicable), and

  • list all individual authors to be credited.

Contributors who do not meet authorship criteria

Individuals who contributed to the work but do not meet authorship criteria should be listed in Acknowledgements, with a brief description of their contribution. Any language editing or editorial assistance used in preparing the manuscript should also be disclosed in Acknowledgements.

Author contributions (entered in the Editorial System)

All authors’ contributions must be declared in the Editorial System using the following categories:

  • A – research concept and design

  • B – collection and/or assembly of data

  • C – data analysis and interpretation

  • D – writing the article

  • E – critical revision of the article

  • F – final approval of the article

Please do not include an “Authors’ contributions” section in the main manuscript file (neither full names nor initials). Information on contributions should be provided only via the Editorial System.

Corresponding author

The submitting author is not automatically designated as the corresponding author. The corresponding author is the primary contact for the Editorial Office and the only author able to view or modify the manuscript in the Editorial System during editorial processing.

The corresponding author role may be transferred to another co-author during the editorial process; however, please note that transferring this role also transfers system access to the manuscript. The corresponding author cannot be changed after acceptance.

Author order and changes to authorship

The order of authors entered in the Editorial System will be used as the author order in the published article. Please verify the author order carefully before final submission.

Changes to authorship after acceptance are not permitted.

Publication ethics: ghostwriting and guest authorship

Ghostwriting and guest authorship constitute scientific misconduct. Any suspected cases will be investigated and may be reported to relevant institutions or bodies, in line with journal ethics policies.

Author names (how they will appear in publication)

Author names will be published exactly as provided in the submission metadata. Please ensure that:

  • full names are provided (do not use initials),

  • given name precedes surname (English convention),

  • patronymics (e.g., in Ukrainian/Russian naming formats) are not included,

  • names are capitalized correctly (including Chinese names).

First author and corresponding author

Each manuscript may have only one first author and one corresponding author (these roles may be held by the same person). The journal does not accept co-first authorship or co-corresponding authorship.
If requested, the journal may mark two selected authors with asterisks and add the note:
“X and Y contributed equally to this work.”

ORCID

Authors who have an ORCID iD are strongly encouraged to provide it during submission. You can register for an ORCID number for free at: https://orcid.org.

Anonymity during peer review

To support blinded peer review, the manuscript file must not contain any information that could identify the authors (including names) in the main text.

Affiliations

Each author must have at least one affiliation provided in the submission system.

Required affiliation format

Affiliations should include:

  • Department / Unit (if applicable)

  • Institution (university, hospital, research institute, company)

  • City, Country

Please do not include:

  • names of states/provinces/regions,

  • full postal addresses,

  • postal/ZIP codes.

Level of detail

Affiliations consisting only of the general institution name (e.g., only “University” or “Hospital”) are considered too general and should be specified further (e.g., department/unit).
This requirement does not apply to authors employed by private companies, where the company name is sufficient.

Students

If an author is a student, please indicate this clearly in the affiliation (e.g., Student, Department of…, University of…).

Multiple affiliations

In the submission system:

  • enter only the preferred/primary affiliation for each author,

  • do not combine multiple affiliations into one field,

  • do not merge two or more affiliations into one entry.

Changes to authorship

Before submitting the manuscript, authors must ensure that the list and order of authors are final and complete.

When changes are allowed

Requests to add, remove, or reorder authors may be considered only before the manuscript is accepted for publication. Changes after acceptance are not permitted.

All authorship changes require approval by the journal Editor.

How to request an authorship change

To request a change in authorship, please submit a signed document to the Editorial Office containing:

  1. the list of original authors,

  2. the list of revised/current authors,

  3. the reason for the requested change,

  4. identification of the corresponding author (if the change affects this role).

Author consent

The request must include written consent signed by all authors, confirming agreement with the proposed change.
This includes signatures from:

  • all original authors, and

  • all authors on the revised list (including authors being added or removed).

Please send the completed document to the Managing Editor:
marek.misiak@umw.edu.pl

Acknowledgements 

The Acknowledgements section may be used to recognize individuals or organizations that contributed to the study but do not meet the criteria for authorship. This may include, for example:

  • scientific or technical advisors,

  • administrative support,

  • language editing services,

  • companies or suppliers who donated or provided materials, equipment, or other resources.

Please note:

  • Funding information must be reported in the Funding sources section (and/or in the designated submission fields), not in Acknowledgements.

  • Conflicts of interest must be disclosed in the Conflict of interest section, not in Acknowledgements.

Names of countries, cities and institutions 

To ensure consistency in indexing and international readability, the journal applies standardized naming conventions for countries, cities and institutions.

Country names

Please use the following country names:

  • China (not: People’s Republic of China)

  • South Korea (not: Korea; not: Republic of Korea)

  • Turkey (not: Türkiye)

  • Czech Republic (not: Czechia)

  • Turkish Republic of Northern Cyprus (TRNC) (use this when the institution is located in TRNC; do not use “Cyprus” in this case)

City names

Please use English names of cities, not local/original spellings, e.g.:

  • Mexico City (not: Ciudad de México)

  • Naples (not: Napoli)

Institution names

Please use official English names of universities, hospitals, clinics, research institutes and other entities, e.g.:

  • National Autonomous University of Mexico (not: Universidad Nacional Autónoma de México)

No states/provinces in affiliations or text

Please do not include names of states, provinces, or regions, either in affiliations or in the main text.

Examples:

  • Xi’an, China (not: Xi’an, Shaanxi, China)

  • Los Angeles, USA (not: Los Angeles, California, USA)

The same rule applies when reporting the location of manufacturers of equipment or software. Please provide city and country only, e.g.:

  • GraphPad Software, San Diego, USA (not: GraphPad Software, California, USA)

Manuscript preparation 

Title of the manuscript

Manuscript titles must be written in sentence case (only the first word, proper nouns, and genus names capitalized). Please avoid specialist abbreviations in the title whenever possible.

Abstract

Structured abstract is required for:

  • Original Papers

  • Research Letters

  • Meta-analyses

Length: 200–300 words, with the following subheadings (in this order):

  1. Background

  2. Objectives

  3. Materials and methods

  4. Results

  5. Conclusions

Unstructured abstract is required for:

  • Reviews

Length: 150–250 words.

Important: The abstract must be entered only in the Editorial System. Do not paste it into the manuscript file.

Graphical abstract

A graphical abstract (GA) is required for papers accepted for publication.

  • The Editorial Office does not provide graphic design or DTP services.

  • Authors must submit a GA in final, publication-ready form.

  • The GA must be uploaded as a separate file in the submission system.

Keywords

Provide 3–5 keywords in the language of the manuscript. Keywords should follow MeSH (Medical Subject Headings / Index Medicus) whenever possible.

Main text

File format

Manuscripts must be submitted in one of the following formats:

  • DOCX, DOC, RTF

Formatting

Main text and reference list must be formatted as follows:

  • Times New Roman 12

  • 1.5 line spacing

Please note:

  • the manuscript file must not include author names/affiliations or the abstract,

  • tables, figures, and reference list must be uploaded as separate files,

  • do not number headings/subheadings.

Text formatting rules

  • Do not use italics (except gene names and taxonomy), bold, or underlining in the text.

  • Use only generic names of drugs.

Word limits

Maximum word count:

  • Reviews / Meta-analyses: up to 7000 words (incl. text, tables, figure legends; excl. references)

  • Original Papers: up to 3000 words (incl. text and figure legends; excl. title page, abstract, references)

  • Research Letters: up to 1500 words (incl. text and figure legends; excl. title page, abstract, references)

Maximum number of illustrations

  • up to 10 tables and 10 figures

  • Research Letters: up to 2 tables and 2 figures

Required section structure

All manuscripts (general structure)

The main text should include the following sections in this order:

  1. Background/Introduction (minimum 1 page)

  2. Objectives

  3. Limitations of the study

  4. Conclusions

Original Papers and Research Letters

Must include the following sections:

  1. Background (minimum 1 page)

  2. Objectives

  3. Materials and methods

  4. Results

  5. Discussion

  6. Limitations of the study

  7. Conclusions

Ethical requirements (humans/animals)

For studies involving humans or animals, authors must include in the manuscript:

  • ethics committee approval (or justification for waiver),

  • for human studies: compliance with the Declaration of Helsinki (or justification for non-applicability),

  • information on informed consent (or justification if not obtained).

Statistical analysis

Authors must follow the journal’s statistical guidelines. All manuscripts containing statistical analyses are subject to independent statistical review by a Statistical Editor (in addition to peer review). Manuscripts that do not meet the statistical standards will not be accepted for publication.

Units of measure

  • Laboratory values must be reported in SI units.

  • Temperatures must be given in °C.

  • Units must follow numbers with a space: 20 mL (not 20mL).

  • All numbers must be written as figures (e.g., 4, not four).

  • If conventional units are used, provide SI equivalents in parentheses at first mention.

Equipment, reagents and software

For all external products (equipment, assays, reagents, antibodies, software), provide:

  • exact model / reagent name / catalogue number,

  • manufacturer name,

  • manufacturer location (city and country only),

  • software version (e.g., IBM SPSS Statistics v. 24.0),

  • for freeware/databases: direct URL to the used version is sufficient.

Abbreviations

  • Abbreviations must be defined at first mention.

  • Do not begin sentences with abbreviations.

  • Abstract and main text are treated as separate texts: abbreviations must be defined in both.

  • Abbreviations used in tables/figures must be defined in each legend, even if defined elsewhere.

  • Avoid non-standard abbreviations; do not use abbreviations in titles.

Tables

  • Tables must be submitted as separate editable files (DOC/DOCX only; not XLS/XLSX).

  • Tables must be cited in the text in numerical order.

  • Do not duplicate data in both text and tables.

  • No empty cells (use “–” where applicable).

  • All abbreviations must be explained in footnotes/legend.

  • References cited in tables must follow the main reference numbering sequence.

Figures

  • Figures must be submitted as separate files (not embedded in the manuscript).

  • Each figure must be numbered consecutively (Fig. 1, Fig. 2, …).

  • Maximum 6 panels per figure (A–F); one panel should contain one chart/image.

  • Figures must be legible on A4 PDF without zooming.

  • Captions must be placed at the end of the main manuscript file.

  • Any third-party copyrighted material requires written permission and proper citation.

Further details: Technical requirements for figures (link)

References

  • References must be numbered consecutively (AMA style; not Harvard).

  • Reference numbers in text must be superscript Arabic numerals without parentheses.

  • Do not cite references in abstract or headings/subheadings.

  • Reference list must follow citation order (not alphabetical).

  • Provide DOI for all references where possible; if no DOI, provide PMID; if neither, provide URL.

  • Do not include unpublished work (“data not shown”), submitted manuscripts, or personal communications in the reference list.

  • Do not paste the reference list into the manuscript file (upload as separate file).

  • Cite the journal as: Polim Med.

Supplementary material

Supplementary material should be deposited in Zenodo and assigned a single DOI for the package:
https://zenodo.org/

Authors must provide:

  • DOI of the supplementary package,

  • numbered files (Supplementary Table 1, Supplementary Figure 1, etc.),

  • one-sentence description of each item.

The DOI and descriptions will be included in the manuscript under Data availability statement.

Originality check (plagiarism screening)

All submissions are screened using iThenticate. Manuscripts with a Similarity Index (SI) ≥ 30% will be returned for revision. Reuse of previously published text (including by the authors themselves) may be treated as plagiarism/self-plagiarism.

Use of AI and AI-assisted technologies

Use of generative AI tools for writing is allowed only to improve language/readability and must be disclosed with human oversight. AI tools cannot be listed as authors.

Disclosure must be included:

  • in the cover letter, and

  • in a manuscript statement (after Conclusions) titled “AI usage in the writing process”, using the following template:

During the preparation of this work the author(s) used [NAME TOOL / SERVICE] in order to [REASON]. After using this tool/service, the author(s) reviewed and edited the content as needed and take(s) full responsibility for the content of the publication.

Use of AI tools to create/alter images is not permitted, except for:

  • basic brightness/contrast/color balance adjustments not affecting scientific meaning,

  • AI used as part of the research methodology (must be described reproducibly in Methods).

Peer review (blinded review)

All manuscripts undergo blinded editorial peer review.

  • At least two independent reviewers are invited.

  • Final decisions are made by the Editorial Board, in line with COPE principles.

Authors must provide:

  • a point-by-point response to reviewers,

  • a revised manuscript with changes marked (red highlight or track changes).

Suggested peer reviewers

Authors must suggest three potential reviewers, who:

  • are from a different country than any author,

  • are experts in a relevant field.

Provide:

  • name,

  • institutional email,

  • link to institutional profile page (if available).

Suggested reviewers must not have a conflict of interest with the authors.

The suggested reviewers cannot have a conflict of interest as described here:
https://www.journals.elsevier.com/journal-of-systems-and-software/policies/conflict-of-interest-guidelines-for-reviewers

Proofs 

Authors are advised to keep a copy of the final accepted manuscript, as proofs will be sent without the manuscript file.

Proof correction policy

Proof corrections should be limited to typographical and production (printer’s) errors only. Substantive changes to the content are not permitted at the proof stage.

Authors must carefully check the proofs and ensure that the final version is free of errors. Responsibility for proofreading rests with the authors.

Deadline

Please return corrected proofs to the Editorial Office within 3 working days.
Delays may result in publication of the paper without corrections or may postpone publication.

How to mark corrections

Corrections must be made directly in the PDF proof using the “Comment” function only.

Please:

  • add comments indicating the exact passages requiring correction,

  • ensure that comments are not locked (the Editorial Office must be able to remove them).

Please do not:

  • edit/overwrite the PDF content directly (text, tables, figures),

  • add watermarks,

  • submit corrections as a separate list.

Direct editing of the PDF renders the proof unusable for production and prevents proper editorial tracking of corrections.

No changes after Ahead of Print publication

Please note that once an article has been published online as Ahead of Print, it can no longer be changed (including author names, affiliations, and author order). This policy follows the requirements of scientific databases in which Polymers in Medicine is indexed.

© Wroclaw Medical University